Trial intelligence / Profile preview

Effectiveness of a Collaborative Deprescribing Intervention of Proton Pump Inhibitors

TCTR20260213005Phase 3Recruiting

Sponsor
Capital University of Science and Technology
Start
Dec 2025
Countries
1
01

Overview

Phase 3 trial in Acid Peptic Disease (APD), sponsored by Capital University of Science and Technology. Started Dec 2025; status: recruiting.

02

Conditions

Acid Peptic Disease (APD)

Beyond the preview

Go deeper on TCTR20260213005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20260213005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call